US Patent Issued to SEOUL NATIONAL UNIVERSITY HOSPITAL, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY on Oct. 27 for "Composition for prevention or treatment of cardiovascular and metabolic disease comprising noranhydroicaritin" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,399, issued on Oct. 27, was assigned to SEOUL NATIONAL UNIVERSITY HOSPITAL (Seoul, South Korea) and KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (Daejeon, South Korea).

"Composition for prevention or treatment of cardiovascular and metabolic disease comprising noranhydroicaritin" was invented by Hyo-Soo Kim (Seoul, South Korea), Hyun-Duk Jang (Seoul, South Korea), Kyung Seop Ahn (Daejeon, South Korea), Sei-Ryang Oh (Daejeon, South Korea), Ji Won Park (Daejeon, South Korea), Ok-Kyoung Kwon (Daejeon, South Korea) and Hyung Won Ryu (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compos...